The conserved protective epitopes of hemagglutinin (HA) are essential to the design of a
universal influenza vaccine and new targeted therapeutic agents. Over the last 15 years …

Influenza virus possesses an RNA genome of single-stranded, negative-sensed, and
segmented configuration. Influenza virus causes an acute respiratory disease, commonly …

Influenza A virus (IAV) is a widespread pathogen that poses a significant threat to human
health, causing pandemics with high mortality and pathogenicity. Given the emergence of …

Derived from bountiful marine organisms (predominantly algae, fauna, and
microorganisms), marine polysaccharides and marine oligosaccharides are intricate …

For decades, immunoglobulin preparations have been used to prevent or treat infectious
diseases. Since only a few years, monoclonal antibody applications (mAbs) are taking flight …

Importance The optimal antiviral drug for treatment of nonsevere influenza remains unclear.
Objective To compare effects of antiviral drugs for treating nonsevere influenza. Data …

Influenza virus infections continue to pose a significant threat to public health. Current anti-
influenza drugs target viral proteins; however, the emergence of resistant strains has …

GUANKE is a Lactobacillus plantarum isolated from the feces of healthy volunteer. We have
previously shown that GUANKE enhances the efficacy of the SARS-CoV-2 vaccine and …

The emergence of drug-resistant strains motivate researchers to find new innovative anti-IAV
candidates with a different mode of action. In this work, molecular modelling strategies, such …

The influenza A virus (IAV) damages intestinal mucosal tissues beyond the respiratory tract.
Probiotics play a crucial role in maintaining the balance and stability of the intestinal …